Recent remarks by Aden Duale have sparked nationwide discussion after he indicated that new medication to help prevent HIV could soon become more widely available. While some interpreted this as a breakthrough “cure,” the reality is both promising and more nuanced: Kenya is stepping into a new phase of advanced HIV prevention tools that could significantly reduce infections.

In Kenya, PrEP is already available in many health facilities, but awareness and uptake have varied. What Duale’s statement signals is a push to expand access and introduce newer options, especially for populations at higher risk.
Among the most exciting developments are long-acting injectable forms of PrEP. Unlike daily pills, these injections can be taken once every few weeks or even months. This is a game-changer for many people who struggle with daily medication routines, offering a more convenient and discreet way to stay protected.
Researchers are also working on even more advanced solutions, including potential HIV vaccines and longer-lasting preventive shots. While these are still under development and not yet widely available, they represent hope for a future where HIV transmission could be drastically reduced—or even eliminated.
It is important, however, to separate optimism from misinformation. There is currently no single permanent vaccine or one-time medication that completely prevents HIV forever. Prevention still depends on consistent use of available methods, regular testing, and public awareness.
Duale’s announcement should therefore be seen as part of a broader effort to strengthen Kenya’s healthcare system and accelerate progress in the fight against HIV. If successfully implemented, expanded access to prevention medication could help thousands of Kenyans stay HIV-free and move the country closer to ending new infections.
As Kenya embraces these innovations, the message is clear: the fight against HIV is far from over—but with the right tools, it is increasingly winnable.